Medicinal products containing codeine for treatment of pain in children: Key messages from the PRAC for consideration
2013.07.11
Active substance: codeine
At its June meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) issued a document with key messages that should be considered when using medicinal products containing codeine for pain relief in children.
PRAC:
risk information - full text (available in German only)